Inventor · disambiguated record
Mike Trower
Also filed as: TROWER MIKE
9 granted patents·6 pending applications·27 citations·filing 2016–2025
86Inventor score
Top patents by PatentIndex Score
15 records- 0192US11767328B2Method of treatment of symptoms of menopauseKANDY THERAPEUTICS LTD·Filed 2023·Granted Sep 26, 2023·3 cites·31 claims
- 0292US11591346B2Method of treatment of symptoms of menopauseKANDY THERAPEUTICS LTD·Filed 2020·Granted Feb 28, 2023·6 cites·34 claims
- 0391US12264164B2Method of treatment of symptoms of menopauseKANDY THERAPEUTICS LTD·Filed 2023·Granted Apr 1, 2025·2 cites·23 claims
- 0491US11787820B2Method of treating certain sex hormone-dependent diseases administering a soft gelatin capsule comprising NK1 and NK3 receptors antagonistsKANDY THERAPEUTICS LTD·Filed 2020·Granted Oct 17, 2023·3 cites·41 claims
- 0587US10774091B2Soft gelatin capsule formulationKANDY THERAPEUTICS LTD·Filed 2019·Granted Sep 15, 2020·6 cites·24 claims
- 0687US10195205B2Uses of dual NK1/NK3 receptor antagonists for treating sex-hormone diseasesNERRE THERAPEUTICS LTD·Filed 2016·Granted Feb 5, 2019·6 cites·4 claims
- 0771US9750739B2Orvepitant for chronic cough therapyNERRE THERAPEUTICS LTD·Filed 2016·Granted Sep 5, 2017·1 cites·11 claims
- 0870US2025154167A1Method of treatment of symptoms of menopauseKANDY THERAPEUTICS LTD·Filed 2025·Application pending·0 cites
- 0968US2021128574A1Novel usesKANDY THERAPEUTICS LTD·Filed 2018·Application pending·0 cites
- 1068US2021236506A1Novel usesKANDY THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1166US2024108621A1Novel usesNERRE THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 1262US11872222B2UsesNERRE THERAPEUTICS LTD·Filed 2021·Granted Jan 16, 2024·0 cites·11 claims
- 1353US2023190740A1An nk-1 receptor antagonist for treating a disease selecting from sepsis, septic shock, acute respiratory distress syndrome (ards) or multiple organ dysfunction syndrome (mods)NERRE THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1449US9907795B2Method of treatment of chronic cough administering orvepitant in combination with other therapeutic agentsNERRE THERAPEUTICS LTD·Filed 2017·Granted Mar 6, 2018·0 cites·15 claims
- 1546US2017326140A1Novel usesNERRE THERAPEUTICS LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mike Trower files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →